Werewolf Therapeutics, Inc. · NASDAQ:HOWL

Werewolf Therapeutics, Inc. shareholders

As of Sep 30, 2026, 44 institutions reported holding Werewolf Therapeutics, Inc., 26.4% of its shares. Largest: Balyasny Asset Management L.P., ADAR1 Capital Management, LLC and Vanguard. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Werewolf Therapeutics, Inc.ChangeFiled
Balyasny Asset Management L.P.3.04M6.3%+1.25MNov 16, 2026
ADAR1 Capital Management, LLC2.02M4.2%newNov 16, 2026
Vanguard1.52M3.1%+139KNov 13, 2026
Lynx1 Capital Management LP658K1.4%no changeNov 16, 2026
Sphera Funds Management LTD.627K1.3%no changeNov 16, 2026
DC Funds, LP589K1.2%no changeNov 13, 2026
Jane Street565K1.2%+313KNov 12, 2026
Citadel554K1.1%newNov 16, 2026
Renaissance Technologies551K1.1%−124KNov 12, 2026
Hrt Financial LP415K0.85%newNov 13, 2026

Werewolf Therapeutics, Inc. insider trades